Related Experiment Video
Updated: May 6, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Antiviral agents for analyzing virus life cycle: chemical genetics for virology
1Department of Virology II, National Institute of Infectious Diseases.
Abstract:
Hepatitis C virus, which affects approximately 170 million people worldwide, is a major causative agent of hepatocellular carcinoma. Anti-HCV treatment is available with the combination of pegylated interferon and ribavirin, and newly approved protease inhibitors. However, because of the diverse anti-HCV efficacy among HCV genotypes and significant side effects, alternative anti-HCV agents are in great demand. Using cell-based systems supporting a part of or the whole HCV life cycle, we identified cyclosporin A, tamoxifen, and benzamide derivatives that inhibited the replication of HCV RNA or the production of infectious HCV particles. In this article, we summarize the mechanistic analyses of the HCV life cycle using these small molecules. Thus, chemical genetics is a powerful approach for revealing molecular mechanisms of the viral life cycle as well as for developing new antiviral agents.
Insights
Researchers identified new antiviral agents, including cyclosporin A, tamoxifen, and benzamide derivatives, that inhibit Hepatitis C virus (HCV) replication. This chemical genetics approach aids in developing novel Hepatitis C treatments and understanding the viral life cycle.
Area of Science:
- Virology
- Hepatology
- Medicinal Chemistry
Background:
- Hepatitis C virus (HCV) infection affects 170 million globally, a leading cause of hepatocellular carcinoma.
- Current treatments (pegylated interferon, ribavirin, protease inhibitors) have limitations due to genotype-specific efficacy and side effects.
- There is a significant need for alternative, effective anti-HCV agents.
Purpose of the Study:
- To identify novel small molecules that inhibit Hepatitis C virus (HCV) replication.
- To elucidate the molecular mechanisms underlying the HCV life cycle using chemical genetics.
- To explore potential new antiviral therapies for Hepatitis C.
Main Methods:
- Utilized cell-based systems supporting partial or complete HCV life cycle.
- Screened small molecules, including cyclosporin A, tamoxifen, and benzamide derivatives.
- Performed mechanistic analyses to understand inhibition of HCV RNA replication and particle production.
Main Results:
- Identified cyclosporin A, tamoxifen, and benzamide derivatives as inhibitors of HCV replication.
- Demonstrated inhibition of HCV RNA replication and/or infectious HCV particle production.
- Provided mechanistic insights into the HCV life cycle through small molecule intervention.
Conclusions:
- Chemical genetics is a powerful strategy for dissecting viral life cycles.
- Identified small molecules show promise as alternative anti-HCV agents.
- This approach facilitates the development of new antiviral therapies for Hepatitis C.
Related Concept Videos
Retrovirus Life Cycles
Subviral Agents
Viruses with RNA Genomes
Viral Replication: Lytic Cycle
Size and Structure of Viral Genomes

